001     179247
005     20240229145537.0
024 7 _ |a 10.1126/sciadv.abh4050
|2 doi
024 7 _ |a pmid:35319989
|2 pmid
024 7 _ |a altmetric:125197016
|2 altmetric
037 _ _ |a DKFZ-2022-00529
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Walle, Thomas
|0 P:(DE-He78)51635089578f68fc9efdb61e6a760b64
|b 0
|e First author
|u dkfz
245 _ _ |a Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8.
260 _ _ |a Washington, DC [u.a.]
|c 2022
|b Assoc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1648641779_12909
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:E055#LA:E055#
520 _ _ |a Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8-dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56dim-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56dim NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy.
536 _ _ |a 315 - Bildgebung und Radioonkologie (POF4-315)
|0 G:(DE-HGF)POF4-315
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Kraske, Joscha
|0 P:(DE-He78)7fb0841f5e88928308e29474e3170818
|b 1
|u dkfz
700 1 _ |a Liao, Boyu
|0 P:(DE-He78)c3341cb95b840ce8a9365b013a464e41
|b 2
|u dkfz
700 1 _ |a Lenoir, Bénédicte
|0 P:(DE-He78)4671d97058e8d2ddb314e6be4de0c403
|b 3
|u dkfz
700 1 _ |a Timke, Carmen
|0 0000-0003-0256-6625
|b 4
700 1 _ |a von Bohlen Und Halbach, Emilia
|0 P:(DE-He78)10877b4f46992f46a4fafc3e16e40eb3
|b 5
700 1 _ |a Tran, Florian
|0 0000-0002-3735-9872
|b 6
700 1 _ |a Griebel, Paul
|0 0000-0001-5671-8183
|b 7
700 1 _ |a Albrecht, Dorothee
|0 P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa
|b 8
|u dkfz
700 1 _ |a Ahmed, Azaz
|0 P:(DE-He78)bac8c2c56238485ecf0475ff14438430
|b 9
|u dkfz
700 1 _ |a Suarez-Carmona, Meggy
|0 P:(DE-He78)7eaaf5131f5096c7ff7de12dde4ceca5
|b 10
|u dkfz
700 1 _ |a Jiménez-Sánchez, Alejandro
|0 0000-0003-1879-7057
|b 11
700 1 _ |a Beikert, Tizian
|0 P:(DE-He78)53d20e6d4d85019eeb3f21bb93ae62fa
|b 12
|u dkfz
700 1 _ |a Tietz-Dahlfuß, Alexandra
|0 0000-0003-1489-3885
|b 13
700 1 _ |a Menevse, Ayse Nur
|b 14
700 1 _ |a Schmidt, Gabriele
|0 P:(DE-He78)e8868a5fc184fe2e756d7e11ad1ac748
|b 15
|u dkfz
700 1 _ |a Brom, Manuela
|0 P:(DE-He78)2e781085118732ec90737b79c643a9d1
|b 16
|u dkfz
700 1 _ |a Pahl, Jens H W
|b 17
700 1 _ |a Antonopoulos, Wiebke
|b 18
700 1 _ |a Miller, Matthias
|b 19
700 1 _ |a Perez, Ramon Lopez
|0 0000-0002-6876-2074
|b 20
700 1 _ |a Bestvater, Felix
|0 P:(DE-He78)89e155931400aa7bb80b79b6be41f979
|b 21
|u dkfz
700 1 _ |a Giese, Nathalia A
|b 22
700 1 _ |a Beckhove, Philipp
|b 23
700 1 _ |a Rosenstiel, Philip
|0 0000-0002-9692-8828
|b 24
700 1 _ |a Jäger, Dirk
|0 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
|b 25
|u dkfz
700 1 _ |a Strobel, Oliver
|b 26
700 1 _ |a Pe'er, Dana
|0 0000-0002-9259-8817
|b 27
700 1 _ |a Halama, Niels
|0 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601
|b 28
|u dkfz
700 1 _ |a Debus, Jürgen
|b 29
700 1 _ |a Cerwenka, Adelheid
|b 30
700 1 _ |a Huber, Peter
|0 P:(DE-He78)3291aaac20f3d603d96744c1f0890028
|b 31
|e Last author
|u dkfz
773 _ _ |a 10.1126/sciadv.abh4050
|g Vol. 8, no. 12, p. eabh4050
|0 PERI:(DE-600)2810933-8
|n 12
|p eabh4050
|t Science advances
|v 8
|y 2022
|x 2375-2548
909 C O |o oai:inrepo02.dkfz.de:179247
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)51635089578f68fc9efdb61e6a760b64
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)7fb0841f5e88928308e29474e3170818
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)c3341cb95b840ce8a9365b013a464e41
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)4671d97058e8d2ddb314e6be4de0c403
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)10877b4f46992f46a4fafc3e16e40eb3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)bac8c2c56238485ecf0475ff14438430
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)7eaaf5131f5096c7ff7de12dde4ceca5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)53d20e6d4d85019eeb3f21bb93ae62fa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 0000-0003-1489-3885
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)e8868a5fc184fe2e756d7e11ad1ac748
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)2e781085118732ec90737b79c643a9d1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 0000-0002-6876-2074
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)89e155931400aa7bb80b79b6be41f979
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)3291aaac20f3d603d96744c1f0890028
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-315
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version)
|0 LIC:(DE-HGF)CCBYNCNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-01-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-01-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCI ADV : 2021
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-09-20T13:50:30Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-09-20T13:50:30Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-09-20T13:50:30Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-08
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2022-11-08
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b SCI ADV : 2021
|d 2022-11-08
920 2 _ |0 I:(DE-He78)E055-20160331
|k E055
|l E055 KKE Translationale Radioonkologie
|x 0
920 0 _ |0 I:(DE-He78)E055-20160331
|k E055
|l E055 KKE Translationale Radioonkologie
|x 0
920 1 _ |0 I:(DE-He78)E055-20160331
|k E055
|l E055 KKE Translationale Radioonkologie
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l D120 Angewandte Tumor-Immunität
|x 2
920 1 _ |0 I:(DE-He78)D240-20160331
|k D240
|l Translationale Immuntherapie
|x 3
920 1 _ |0 I:(DE-He78)W210-20160331
|k W210
|l Lichtmikroskopie
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E055-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a I:(DE-He78)D240-20160331
980 _ _ |a I:(DE-He78)W210-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21